Insights on Clinical Trials

  1. 5 Strategies For Designing Successful Complex Rare Disease Trials 3/31/2026

    Rare disease trials demand inventive design. Uncover creative strategies that help sponsors overcome tiny populations, complex endpoints, and operational hurdles to advance meaningful breakthroughs.

  2. Biotech's Next Wave: Breakthroughs Fueling Innovation And Investment 3/30/2026

    Biotech is shifting fast as scientific advances spark new investment and development models. Learn how emerging trends are propelling next‑generation therapies at record speed.

  3. Galvanizing Large And Small For Clinical Success 3/25/2026

    See how two academic investigators accelerated corneal regeneration and lung fibrosis therapies from preclinical research to clinical trials by leveraging scalable GMP solutions and regulatory-ready materials.

  4. 10 Clinical Research Practices That Feel Like Compliance (But Aren't) 3/24/2026

    Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.

  5. Zymeworks Shares Its Design Rationale (And Wins) In Early-Phase ADC Trials 3/24/2026

    Zymeworks CMO Sabeen Mekan, MD, explores how scientific gains in ADC therapies have influenced first-in‑human trial design.

  6. Overcome Patient-Level Access Barriers For New Medicine 3/23/2026

    Explore market access from the patient’s perspective and identify five aspects of how people get hold of medicine that should inform commercialization.

  7. Compliance, Costs, And Site Readiness In CAR-T Clinical Trials 3/19/2026

    Navigate CAR-T trial complexity: uncover key compliance, budgeting, and site readiness strategies to ensure safe, efficient, and successful patient care.

  8. Managing Operational Challenges In CAR-T Clinical Trial Logistics 3/18/2026

    Coordinating CAR-T trials means managing tight timelines, cryogenic handling, staffing gaps, and chain-of-identity risks where even small missteps can delay care.

  9. Lessons From Bringing A Novel T Cell Class For Autoimmune Diseases Into The Clinic 3/13/2026

    Tr1X Bio Co-founder and CEO David de Vries explains how moving Type 1 regulatory T Cell (Tr1) therapies into new indications reshapes every facet of first-in-human trial design.

  10. Why AI Matters In Early Phase Clinical Trials 3/11/2026

    AI speeds early‑phase development by streamlining data review, enabling structured queries, accelerating PK/PD work, and revealing biomarker patterns — boosting efficiency with expert oversight.